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Abstract
The specific use of engineered nanostructures in biomedical applications has become very 
attractive, due to their ability to interface and target specific cells and tissues to execute 
their functions. Additionally, there is continuous progress in research on new nanostruc-
tures with unique optical, magnetic, catalytic, and electrochemical properties that can be 
exploited for therapeutic or diagnostic methods. On the other hand, as nanostructures 
become widely used in many different applications, the unspecific exposure of humans to 
them is also unavoidable. Therefore, studying and understanding the toxicity of such mate-
rials is of increasing importance. Previously published reviews regarding the toxicological 
effects of nanostructures focuses mostly on the cytotoxicity of nanoparticles and their inter-
nalization, activated signaling pathways, and cellular response. Here, the most recent stud-
ies on the in vitro cytotoxicity of NPs, nanowires, and nanorods for biomedical applications 
are reviewed and divided into two parts. The first part considers nonmagnetic metallic and 
magnetic nanostructures. While part 2 covers carbon structures and semiconductors. The 
factors influencing the toxicity of these nanostructures are elaborated, to help elucidating 
the effects of these nanomaterials on cells, which is a prerequisite for their save clinical use.
Keywords: nanoparticles, nanowires, nanorods, biocompatibility, cytotoxicity, 
nanomedicine
1. Introduction
Nanostructured materials are defined as possessing one of their dimensions in the range of 
1–100 nm, according to the American Society for Testing and Materials (ASTM) international 
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standards definition [1]. For nanoparticles (NPs), which can be of more or less spherical or 
cubical shape, two dimensions are required to be within this range. In contrast, the shape of 
nanorods (NRs) is in one dimension much larger than in the others. For a small aspect ratio 
(<10), both their length and diameter are in the nanoscale, whereas NRs with a large aspect 
ratio (>10) only have their diameter within this scale, and are often called “nanowires” (NWs). 
Nanostructures within this specific size scale show unique size-dependent optical, magnetic, 
catalytic, and electrochemical properties, among others, as well as high surface to volume 
ratios. Moreover, their shape, surface chemistry, and chemical composition can be used to tai-
lor specific properties, making nanostructures highly versatile for different applications [2, 3].
The size scale of nanostructures is within the range of several biomolecules, such as proteins 
and antibodies, allowing specific interactions to occur between them. This, when coupled with 
the high surface to volume ratios and tunable sizes and properties, makes nanostructures prime 
candidates for biomedical applications such as imaging, drug delivery, and therapy [4–6]. 
Examples of applications include the use of NPs as magnetic resonance imaging (MRI) contrast 
agents [7, 8], tissue engineering [9–11], as well as the recent focus on hyperthermia and cancer 
cell eradication with the use of NPs and NRs [12–17]. Such applications, if they are aimed for a 
clinical setting, ultimately require a direct NP/NR exposure in the form of ingestion or intrave-
nous delivery into the body. Naturally, there is a rigorous testing required before any new drug 
formulation is approved for the clinical use in order to ensure their safety and effectiveness. 
Currently, very few NP-based drugs have been approved by the Food and Drug Administration 
and are commercially available. Examples include GastroMARK, used as an MRI contrast agent 
to enhance the delineation of the bowel, and ferumoxytol, an iron-replacement formulation 
approved for adults with chronic kidney disease with an iron deficiency [18].
Within this scope, biocompatibility and cytotoxicity data are of paramount importance to 
evaluate the potential of nanostructures for biomedical applications. Nanostructures are nor-
mally engineered to interface and target specific cells or tissues to execute their functions, 
raising questions about their toxicological effects. For instance, there are several character-
istics involved in the toxicity of fiber-like nanomaterials, such as shape, length, chemical 
composition, agglomeration, and purity, making them suitable to fit the “fiber toxicological 
paradigm” according to the World Health Organization (WHO) criteria used to describe the 
toxicity of asbestos fibers [19]. Further, nanostructures are usually tuned for biocompatibility 
on top of the desired biomedical function, with the most relevant aspects that influence their 
toxicity being the material [20], size and shape [21], surface charge [22], and surface function-
alization [23]. In vitro studies, while not able to give a complete insight into the biocompatibil-
ity of nanostructures, have a high importance, due to their easy implementation, and provide 
valuable cytotoxicology data regarding the safety of the use of nanostructures in biomedical 
applications. Previously published reviews regarding the biosafety of nanostructures include 
that of Lewinski et al. [24] and Zhao et al. [25]. The former focuses mostly on the cytotoxicity 
of NPs of different materials, whereas the latter is a more in depth review of the internaliza-
tion, activated signaling pathways, and cellular response of different kinds of NPs.
Here, we review relevant studies assessing the in vitro cytotoxicity of both nanoparticles (NPs) 
and nanowires (NWs)/nanorods (NRs) with the potential to be used in biomedical applica-
tions. Due to their prevalence within the applied nanomaterials in biomedicine, this review 
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covers various materials from four different classes (on Scopus almost 50% of all publica-
tions related to cytotoxicity, since the year 2000, fall within these materials) that are typically 
considered in the context of nanomaterials for biomedical applications. The first part of this 
review covers nonmagnetic metals and magnetic materials, while the second part covers car-
bon structures and semiconductors. An overview of the materials and structures covered, 
together with the various intracellular uptake mechanisms, is given in Figure 1.
2. Nonmagnetic metallic nanostructures
2.1. Gold nanoparticles
Gold (Au) NPs are some of the most heavily used nanostructures in biomedical applications, 
most notably in medical imaging and therapy. The absorbance and fluorescence of Au NPs are 
higher than that of bulk Au and they can be finely tuned from the visible spectrum to the near 
infrared by changing their size and morphology [26]. Au can also readily bind different kinds 
of functionalizing molecules, giving them great versatility [27]. These properties make Au 
nanostructures popular candidates for X-ray-based imaging and radiotherapy, as well as pho-
tothermal therapy, when coupled to their ability to transform absorbed light into heat [26–30].
Two of the first cytotoxicity studies with Au NPs were performed by Tkachenko et al. [31]. In 
their first approach, they found that NPs conjugated with bovine serum albumin (BSA) and 
different peptides could enter the cell cytoplasm via an energy-dependent, receptor-mediated 
Figure 1. Schematic of the pathways for intracellular uptake of different materials and structures.
Review of In vitro Toxicity of Nanoparticles and Nanorods: Part 1
http://dx.doi.org/10.5772/intechopen.76365
211
endocytosis pathway, with a decrease in cell viability of only around 5%, using the lactate 
dehydrogenase (LDH) colorimetric assay. The following year, they tested the same principle 
in three different cell lines and found that the uptake of Au NPs, as well as their ultimate fate 
(endosomal or nuclear), was cell dependent [32]. Later, Goodman et al. tested the effects of 
cationic and anionic Au NPs in the metabolic activity of red blood COS-1 cells, and showed 
that the former are more cytotoxic, probably due to them being drawn by the cell membrane’s 
negative charge and then taken up [33]. A different approach using human leukemic K562 
cells was performed by Connor et al. using different surface modifiers and the 3-(4,5-dimeth-
ylthiazol-2yl)-2,5-diphenyltetrazolium bromide (MTT) assay, concluding that, despite the Au 
fabrication precursor being cytotoxic, Au NPs are inherently not, even though they are inter-
nalized and engulfed in endocytic vesicles [34]. This last finding was also confirmed by Chan 
and colleagues, who reported a size-dependent, clathrin-mediated uptake of citric acid, and 
transferrin-coated NPs in HeLa cells (Figure 2) [35, 36]. Similarly, size-dependence cytotoxic-
ity was subsequently reported by Pan et al. [37] They showed that fibroblasts, epithelial cells, 
macrophages, and melanoma cells incubated with small (1.4 nm) Au NPs for 2 days have an 
IC50 ranging from 30 to 56 μM, whereas the same cells can tolerate concentrations 60-fold higher, when changing the particle diameter to 15 nm. The same group then went on to con-
firm the size-dependent cytotoxicity of Au NPs coated with TPPMS, now extending their find-
ings to elucidate a necrotic death pathway in HeLa cells, due to oxidative stress, intracellular 
formation of reactive oxygen species (ROS) and a compromised mitochondrial activity [38].
Figure 2. Size-dependent uptake of Au NPs of different sizes in HeLa cells at different positions from B-F, as observed 
by TEM. While (A) Quantify the number of each Au NPs per vesicle. Adapted with permission from Chithrani et al. [35]. 
Copyright 2006 American Chemical Society.
Cytotoxicity212
The cytotoxicity of Au NPs has also been tested in other relevant cell lines, such as the alveolar 
type II-like A549 and NCIH441 [39]. Using a combination of metabolic activity, cell prolifera-
tion, and release of LDH assays, it was determined that 9.5 nm Au NPs, though internalized and 
stored in endocytic vesicles, do not have an effect on either of the cell lines’ metabolic activity. A 
50% decrease in cell proliferation was detected for A549 cells after 24 hours of exposure, decreas-
ing further as time progressed. A mild dose-dependent LDH release was also reported for 24 
and 48 hours for Au NP concentrations up to 0.7 mM, although after 72 hours, the release was 
significantly higher for this concentration, at around 35 and 90% for A549 and NCHIH441 cells, 
respectively. Macrophages have also been subjected to cytotoxicity assessments using Au NPs 
[40]. The results in this case are particularly relevant, due to their shedding light on a potential 
immunological response. Au NPs of three different sizes (2–4, 5–7, and 20–40 nm) were tested 
in macrophage J774 A1 cells at two concentrations, 1 and 10 ppm. Whereas only the small and 
medium-sized NPs produced a slight decrease in cell proliferation for the lower concentration, 
NPs of all three sizes decreased cell proliferation to around 30–40% for the 10 ppm concentra-
tion. Au NPs were shown to be inside vesicles in the cytoplasm, as was reported for human leu-
kemic [34], HeLa [35], and alveolar type II-like cells [39]. Additionally, it was reported that Au 
NPs upregulate the expression of interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor necrosis 
factor (TNF-α). This data show that macrophages, being one of the principal immune effector 
cells, activate a pro-inflammatory response, when in the presence of Au NPs of either size.
Cho et al. looked closely at the effects of different surface functional groups on the uptake and 
cell membrane adsorption of Au NPs by breast cancer SK-BR-3 cells [41]. They tested Au NPs 
of two sizes (15 and 45 nm) with three different surface groups: poly(ethylene glycol) (PEG), 
anti-HER2, and poly(allylamine hydrochloride) (PAH). The smaller NPs were found to be 
more readily internalized than the larger ones, in contrast with previous findings [35, 36]. The 
PAH-modified NPs showed the greatest amount of internalization, followed by anti-HER2 
and then PEG NPs. Using inductively coupled plasma mass spectrometry (ICP-MS) and an 
etching method to remove the NPs adsorbed to the cell membrane [42], they were able to 
distinguish between internalized nanoparticles to those that remained attached to the cell 
membrane and found that PEG-modified NPs had the lowest adsorption rate, thereby inter-
nalizing most of the NPs that came in contact with the cells. PAH-modified NPs had a very 
strong affinity to the cell membrane, probably due to their electrostatic interactions.
A more recent study compared NPs of 10, 25, and 50 nm and found that larger NPs are more 
readily taken up by NRK cells [43]. It was also reported that Au NPs enter the cells through 
endocytosis, ultimately accumulating in lysosomes and impairing their degradation capacity 
through alkalinization: Au NPs cause the dissociation of the V1 protein from the acidification-
regulator complex H+(V)-ATPase, down-regulating its activity. The impairment of lysosomal 
function thus reduced the turnover of autophagosomes, carriers of intracellular content to 
their final degradation in lysosomes, leading to their accumulation in the cell cytoplasm.
2.2. Gold nanorods and nanowires
Gold NRs and NWs, unlike NPs, possess a transverse and a dominant longitudinal plas-
mon [44]. This intense absorption band is near the infrared region, which biological tissue 
hardly absorbs, thus making these Au nanostructures attractive in the biomedical field. Early 
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cytotoxicity data showed that HeLa cells incubated with PEG-stabilized NRs at concentra-
tions up to 0.5 mM survived with more than 90% viability after 24 hours, as per MTT assay 
[45]. Takahashi et al. observed similar viability effects under the same conditions, but using 
NRs modified with phosphatidylcholine [46]. Chithrani et al. reported that an increased 
uptake was observed for NRs in terms of the number of particles per cell with NRs with 
smaller aspect ratios coated with citric acid ligands [35] and transferrin [36]. Similarly, NRs 
of varying surface charges provided by layers of polyelectrolyte coatings seem to maintain 
a cell viability of around 90%, with an increased cellular uptake observed with NRs with a 
positive surface charge [47]. These results were later confirmed using NRs coated with the 
polyelectrolytes polyacrylic acid (PAA) and PAH, with human colon cancer HT-29 cells show-
ing 90% viability after incubation with 0.4 nM Au NRs with either coating [48]. Cell growth 
was also reported not to be impaired, when compared with control cells, although higher 
internalization numbers were found for PAH-coated NRs compared to PAA ones. This is in 
agreement with previous findings [47]: positively charged particles (PAH-coated) are more 
readily taken up, when compared to negatively charged ones (PAA-coated), possibly due to 
the cell membrane’s negative charge attracting the positively charged particles, leading to a 
higher membrane adsorption, as was observed with Au NPs [33, 41].
More recent studies have continued the analysis of the toxicological properties of Au NRs 
with a higher aspect ratio, or Au NWs, as they provide enhanced properties such as absorp-
tion and scattering, due to their increase in length [49]. One of the first approaches aimed 
to compare the cytotoxic effects of Au NRs with Au NWs with an aspect ratio 10 times 
larger [50]. Both instances of particles were coated either with tannic acid (TA) or carboxyl-
ated PEG (PEG-COOH) and the cytotoxicity to human keratinocyte cells was evaluated 
using the (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-
2H-tetrazolium) (MTS) assay, an indicator of mitochondrial metabolic activity similar to 
the MTT assay. Following the same trend as previous cytotoxic data with surface-modified 
Au NRs, both TA and PEG-COOH-coated Au NRs showed a cell viability of up to 90% after 
24 hours of incubation and for concentrations as high as 100 μg/mL; however, in the case 
of Au NWs, TA decreased the cell viability to around 70% at the 50 μg/mL concentration, 
whereas PEG-COOH-Au NWs maintained the viability above the 90% mark. These results 
indicate that, as Au NRs, Au NWs show very low cytotoxic potential, though specific sur-
face coatings may elicit a toxic response. The authors also reported an increased uptake 
for Au NWs, when compared with NR independent of the surface coating. However, the 
values are reported in mass of Au per cell, which could be explained by the amount of 
material, due to the increase in size, and not be a clear representation of the amount of 
particles internalized.
2.3. Silver nanoparticles and nanowires
Silver (Ag) NPs have proven themselves greatly useful for their antimicrobial activity [51] and 
they are widely used in therapeutics and as a treatment for burns [52]. Naturally, a plethora 
of toxicity assessment studies has been carried out in order to understand the potential side 
effects of these nanostructures. The first cytotoxicity studies observed the effects of NPs on 
metabolic activity and membrane damage through LDH leakage, as well as the dependence 
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of the generation of ROS on particle size and the evaluation of the inflammatory response 
[53–55]. In all three studies, a dose-dependent decrease in mitochondrial metabolic activity 
and an increase in LDH leakage were reported for Ag NPs of 15 nm in rat liver BRL 3A cells, 
C18-4 germline stem cells, and macrophages for doses up to 75 μg/mL. Changes in cell mor-
phology and uptake of NPs were also reported, with low levels of apoptosis. Interestingly, 
larger NPs (55 nm) induced a lesser cytotoxic response in macrophages, a result that can 
be attributed to the larger agglomerates not being easily internalized. Additionally, Ag NPs 
significantly impacted ROS generation and the release of inflammatory mediators including 
TNF-α, MIP-2, and IL-1β in macrophages for doses starting at 5 μg/mL. In contrast, Yen et al. 
reported no upregulation of the pro-inflammatory genes TNF-α, IL-1, and IL-6, though the 
doses tested were considerably higher [40].
It was later confirmed by Miura et al. that the ROS-related genes ho-1 and mt-2A are upregu-
lated in HeLa cells [56], further cementing its role in the cytotoxic response. On the other hand, 
Autrup and co-workers showed that polyvinylpyrrolidone (PVP)-coated Ag NPs of 70 nm in 
diameter seemed to elicit both an apoptotic and necrotic response in THP-1 monocytes [57] 
and human alveolar A549 cells [58]. Although necrosis was markedly higher, the effect could 
be a progression from an early apoptotic stage to a late apoptotic/necrotic one.
Other parameters, such as genotoxicity, have also been studied. Using human lung fibro-
blast IMR-90 cells and glioblastoma U251 cells as test models, AshaRani et al. concluded that 
starch-coated Ag NPs (6–20 nm in size) are taken up and reside inside the mitochondria and 
nucleus and, on top of generating ROS and reducing the metabolic activity and cell viability 
(Figure 3), they also reduced the ATP content of the cells and induced DNA damage and 
chromosomal aberrations in a dose-dependent manner. The latter resulted in cell cycle arrest 
in the G2/M phase with no significant cell death observed, possibly due to the repair of DNA damage [59]. On the other hand, RAW 264.7 macrophage cells exposed to increase concen-
trations of 70 nm Ag NPs showed a significant increase in TNF-α, protein, and gene levels. 
The secretion of nitric oxide, a second messenger in the inflammatory response, as well as 
Figure 3. Cytotoxicity of Ag NPs on U251 glioblastoma and IMR-90 fibroblast cells. Different concentrations of NPs with 
sizes ranging from 6 to 20 nm in diameter were cocultured with the cells for incubation times up to 72 hours. Adapted 
with permission from AshaRani et al. [59]. Copyright 2009 American Chemical Society.
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the gene expression of matrix metalloproteinases (MMPs) MMP-3, MMP-11, and MMP-19, 
which play a key role in extracellular matrix degradation and can be activated through ROS 
were also reported [60]. Further, another parameter that has been observed is the effect of Ag 
NPs of different sizes on the differentiation of embryonic stem cells [61]. Differentiation into 
cardiomyocytes was inhibited in a dose-dependent manner, with Ag NPs of 20 nm having a 
stronger effect compared to larger ones.
In recent studies, it has been proposed that the intracellular release of Ag ions from the NPs is 
one of the causes of their cytotoxicity. Singh et al. showed that, after being taken up through 
scavenger receptor-mediated phagocytosis in macrophages, intracellular dissolution of Ag NPs 
had a 50 times faster rate than in water, at around 5% of the total dose being dissolved [62]. It 
was suggested that Ag ions are a cytotoxic response initiator in human lung BEAS-2B cells [63].
Ag NW cytotoxicity, on the other hand, has not been extensively studied. In a comparative 
study of Ag NWs with a diameter of around 100 nm and lengths of 3, 5, 10, 14 and 28 μm, 
it was found that only the wires with a length of 28 μm could elicit a significant decrease in 
cell proliferation and membrane instability in THP-1 cells [64]. Using light microscopy and 
back-scattered electron imaging, it was also proven that NWs of 14 and 28 μm are not prop-
erly internalized, resulting in a frustrated phagocytosis, or an inability to engulf its target, 
which is in turn an initiator of the inflammatory response. In a different approach, red blood 
cells exposed to Ag NWs of 2 μm in length and a diameter of 40 nm were confirmed to suffer 
structural changes, aggregation, and hemolysis in a dose-dependent manner [65].
3. Magnetic nanostructures
3.1. Magnetic nanoparticles
Magnetic NPs are usually made of a magnetic core bound within a shell that allows them to 
be functionalized with relevant ligands and gives them stability in solution [66]. Their main 
advantage is their ability to be manipulated using an external magnetic field, making them 
attractive for different biomedical applications. These include cell labeling and MRI contrast 
agents [67, 68], targeted drug delivery [69, 70], and cancer cell eradication [71, 72]. Iron oxide 
NPs such as magnetite (Fe
3
O
4
) and maghemite (γ-Fe2O3) are the most widely used magnetic NPs [73]. Sufficiently small Fe oxide NPs exhibit superparamagnetism: NPs become magne-
tized under an external magnetic field, but loose do not possess any remanent magnetization 
once the field is removed [74]. Superparamagnetic Fe oxide NPs (SPIONs) can be manipulated 
and guided by a magnetic field without losing the stable colloidal suspension, when there is 
no field applied, a quality that is attractive for biomedical applications.
3.2. Superparamagnetic iron oxide nanoparticles
Initial cytotoxicity studies compared the cytotoxic effects of bare magnetite NPs with PEG-
coated ones in primary human fibroblast hTERT-BJ1 cells, and found that, whereas cells 
treated with 40–50 nm PEG-coated NPs for 24 hours remained 100% viable for concentrations 
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as high as 1 mg/mL, uncoated, 10–15 nm NPs reduced the viability to around 70% at a concen-
tration of 250 μg/mL [75]. Similar results were observed with pullulan-coated and uncoated 
NPs within the same size range [76]. There, it was also shown that bare NPs significantly 
reduce cell attachment and disrupt the distribution of actin filaments and microtubules, 
while also being taken up at a higher rate compared to the coated ones. Uncoated NPs were 
also reported to have cytotoxic effects only at higher doses (100–250 μg/mL) in terms of cell 
viability and LDH leakage in rat liver BRL 3A cells [53]. In agreement with these findings, 
hydroxy-tetramethylammonium-coated SPIONs at higher concentrations (23 mM) did not 
induce a reduction inviability of kidney COS-7 cells, though the time of incubation tested 
was only of 4 hours [77].
Ma et al. studied the uptake of 30 nm aminosilane-coated NPs by human lung cancer SPC-
A1 and human lung WI-38 cells and found that the intracellular Fe content was 15 times 
higher for the cancerous cells compared to normal counterparts [78]. As with other NPs, they 
are likely endocytosed through phagocytosis and found within endosomes and lysosomes. 
Human monocytes-macrophages were also found to endocytose SPIONs and retained them 
inside lysosomes, remaining highly viable with no apparent activation of pro-inflammatory 
cytokines for up to 14 days following the incubation with 0.4 mg/mL SPIONs [79].
Using bare 20–30 nm magnetite NPs, Karlsson et al. tested other parameters of cytotoxicity 
in the human alveolar A549 cells, such as DNA damage and intracellular ROS [80]. No DNA 
damage or intracellular ROS were found for doses up to 40 μg/cm2, although a slight oxidative 
DNA lesion was found at this dose. In contrast, another study showed that uncoated SPIONs 
elicited a significant level of apoptosis on mouse fibroblasts (L929), whereas PVA-coated ones 
did not show a loss of cell viability, apoptosis, necrosis, or cell cycle arrest for up to 72 hours of 
incubation and concentrations up to 200 mM [81]. However, an increase in the concentration 
to 400 mM did induce apoptosis and cell cycle arrest, possibly due to DNA damage through 
oxidative stress. Naqvi et al. obtained similar results for Tween 80-coated NPs in macrophage 
J774 A1 cells: >95% cell viability for low concentrations (25–200 μg/mL) and low incubations 
times, with a decrease to 55–65% for higher concentrations (300–500 μg/mL) associated to an 
apoptotic death pathway through ROS generation [82].
In contrast to previous findings, both citric acid and dextran-coated NPs were found to pro-
duce a dose-dependent cytotoxicity in human umbilical vein endothelial cells (HUVECs) [83]. 
Concentrations as low as 0.1 nM decreased the cell viability for both NPs to around 80% after 
24 hours and increasing the value to 20 nM would decrease the cell viability to less than 15%. 
Additionally, as shown by Soenen et al. [84], actin filaments and microtubules appeared dis-
rupted, thinner, and less organized and vinculin adhesion points were diminished. Further, 
NPs also reduced the migration and vasculogenesis capabilities of HUVECs. Similar results 
regarding cell attachment and cytoskeleton morphology were also reported in a multipara-
metric study with NPs with different coatings on various cell lines [84].
With an aim to understand the differences in cytotoxicity between the charges provided by 
different coatings on SPIONs, a study showed that when different functional groups were 
added in order to provide either a positive or negative charge on SPIONs, cell viability and 
cell membrane integrity remained above 85% up to 24 hours for doses as high as 1000 ppm 
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on L929 fibroblasts for all the coatings tested [85]. As observed for other types of NPs, the 
positively charged NPs were more readily taken up than negatively charged ones. Similarly, 
ROS generation was not significantly different. However, the positively charged and highest 
negatively charged NPs showed DNA damage starting from concentrations of 200 ppm. In 
agreement with this, another study using HCM (heart), BE-2-C (brain), and 293T (kidney) 
cell lines reported similar results [86]. There, bare, positively, and negatively charged NPs 
all showed a dose-dependent response for doses up to 36 mM, with positively charged NPs 
being more cytotoxic for the three cell lines, suggesting a cell-specific response. Gene expres-
sion analysis showed that genes that were mainly altered were those related to apoptosis, cell 
cycle, and cell proliferative responses, most probably due to ROS.
More recent studies have focused on looking at other parameters to better understand the 
cytotoxic response. A size-dependent response was observed for uncoated NPs of 5 and 
30 nm, with only the latter inducing a significant increase in ROS generation, whereas dex-
tran-coated and PEG-coated did not have an effect on ROS levels [87]. Khan et al., on the 
other hand, studied the effects of SPIONs on autophagy, a homeostasis mechanism used to 
degrade proteins and organelles for multiple functions [88]. They proved that ROS induces 
autophagy through the mTOR pathway only on human alveolar cancer A549 cells, and not 
on normal human lung fibroblast IMR-90 cells, while the authors attributed the autophagy 
to be involved with cell death. Lastly, Singh et al. observed a different cytotoxic response 
and uptake related to the Fe redox state (magnetite vs. maghemite) in human lymphoblas-
toid MCL-5 cells [89]. While no significant difference was found between these two states in 
terms of uptake, a decrease in the serum concentration drastically increased the uptake for 
dextran-coated maghemite NPs and this specific kind of NPs was the only one reported to 
elicit a genotoxic response.
3.3. Magnetic nanowires
Magnetic NWs possess tunable lengths and diameters and can be functionalized to provide 
specific targeting and biocompatibility. Depending on the fabrication method and its param-
eters, as well as precursor materials, the magnetic properties of NWs can be finely modulated 
[66, 90]. Magnetic NWs have anisotropic structures with high aspect ratios, which allow them 
to exert torques when under a magnetic field [91]. Additionally, they possess higher magneti-
zation values per unit of volume when compared to NPs, allowing them to exert larger forces 
[92]. These qualities have made magnetic NWs prime candidates for different biomedical 
applications, including cell separation and guidance [91–93], targeted drug delivery [94, 95], 
and cell eradication [15, 16, 96, 97].
The cytotoxicity of Fe NWs was first characterized by Song et al. on HeLa cells [98]. Using 
uncoated NWs of <10 μm in length and 50 nm in diameter, they determined that Fe NWs 
have no significant effect on the cell viability and proliferation for concentrations up to 10,000 
NWs per cell and for incubation times up to 72 hours. Fe NWs were internalized either as 
single NW, bundles or as aggregates, mainly localizing in the cytoplasm and inside vesicles, 
but not inside cell nuclei. Later, Safi et al. proved the same intracellular distribution in fibro-
blast NIH/3T3 cells using maghemite NWs of <15 μm and identified such vesicles as late 
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endosomal or lysosomal endosomes (Figure 4) [99]. It was concluded that NWs are degraded 
by cells and cut into shorter pieces, possibly by the decrease in pH occurring in lysosomal 
compartments [100]. Along with no significant decrease in cell viability, no ROS were found 
after 4 hours of incubation for doses up to 170 NWs per cell. In a recent study, NWs with iron 
core and iron oxide shell were compared to pure iron NWs and tested on HCT 116 cells. The 
experiments confirmed the high cell viability values found for iron NWs before and revealed 
even higher values for the core/shell NWs [101]. An additional advantage of the core/shell 
NWs is the possibility to tune their magnetic properties to the specific requirements of vari-
ous applications.
Studies with Ni NWs first showed a similar distribution to that of Fe NWs: Ni NWs of 20 μm 
in length and 200 nm in diameter activated cell membrane receptors associated with metal-
loproteins, thereby being internalized, triggering lysosomal function in the process and 
localizing inside them around the cell nucleus [102]. Lamellipodium extensions, due to cell 
tethering and re-alignment, were also a consequence of Ni NW internalization, possibly due 
to a cell stiffening response. The same group then studied the biocompatibility of Ni NWs 
on human monocyte THP-1 cells using high content analysis [103]. Measuring cell viability 
Figure 4. NIH/3T3 fibroblasts incubated with maghemite (γ-Fe2O3) NWs during 24 hours. The NWs were found inside membrane-bound compartments, identified as late endosomal or lysosomal endosomes, b) and d) are zoomed images 
from a) and b) respectively. Adapted with permission from Safi et al. [99]. Copyright 2011 American Chemical Society.
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and membrane permeability, they found Ni NWs to be nontoxic for low incubation times 
(<10 hours) and concentrations (<100 NWs per cell). Hossain and Kleve then investigated the 
effects of Ni NWs on human pancreatic adenocarcinoma Panc-1 cells [104]. Using NWs of 
around 6.5 μm in length and 215 nm in diameter, a dose-dependent cytotoxic response was 
shown, including ROS generation and the induction of apoptosis and cell cycle arrest in the 
G
0
/G
1
 phase. A similar response was then reported for HeLa cells, along with mitochondrial 
membrane depolarization [105].
We reported the cytotoxicity of Ni NWs in human fibroblast WI-38 cells [106] and human 
colorectal carcinoma HCT 116 cells [107]. Whereas WI-38 cells showed no significant 
decrease of cell viability up to doses of 120 μg/mL for 24 hours of incubation and the 
viability of HCT 116 cells decreased significantly at the same incubation time for doses 
as low as 5 μg/mL. For both cell lines, NWs were internalized and appeared in the cytosol 
inside membrane-bound compartments, possibly lysosomes, as shown previously [102], 
with the internalization in HCT 116 cells taking place through the phagocytosis pathway. 
Apoptosis was also confirmed to be the cell death pathway, which would later progress 
into secondary necrosis and induce cell membrane instability and LDH leakage. Lastly, it 
was also confirmed that Ni2+ is released intracellularly following NW uptake, due to the 
acidic pH inside the lysosomes. Although the percentage of this intracellular dissolution is 
low compared to the total dose, it is plausible that the leeched Ni2+ contributes to the cyto-
toxic effects observed. It should be mentioned that Au-coated Ni NWs showed an improved 
biocompatibility, possibly due to the Au reducing the degree of dissolution, while also 
providing a functionalization layer [108, 109]. Similarly, we have reported the stabilization 
of Fe NWs by coating with a poly(MPC) homopolymer in order to increase dispersion and 
biocompatibility [110].
4. Conclusion
Recent studies on the in vitro cytotoxicity of nonmagnetic and magnetic structures in biomedi-
cal applications were reviewed, taking into account nanoparticles and nanowires/nanorods. 
A summary of the results of representative studies is provided in Table 1.
Comparisons between the cytotoxicities of those different nanomaterials are generally diffi-
cult to make, due to the vast range of methods, concentrations, dimensions, cell lines, etc. For 
instance, the concentrations reported in the different studies were typically evaluated using 
either ICP or cryogenic TEM. However, the concentration or dose of the nanomaterial plays a 
significant role in the cytotoxic response as well as the biomedical applications.
While the concentrations and exposure times are critical factors, the toxicity of these nano-
structures is also material dependent. These relations can be seen in Figure 5, which presents 
the average values reported for the cell viabilities (ignoring differences in concentrations, 
incubation times, etc.), when exposed to the nanomaterials in the studies covered in Table 1. 
Fe nanomaterials showed higher cell viabilities than Au ones.
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In addition, the particle size plays a major role in the cytotoxic properties of the nanostructure, 
whereby both the cellular uptake efficiency and pathway are affected, with smaller particles 
being internalized faster than larger ones.
The induction of ROS after dissolving the nanostructures in the lysosomes was shown to be 
the primary underlying cause of the toxicity in several cases, leading to cell death through the 
apoptotic pathway, due to ROS generation and mitochondrial damage. The acidic condition 
inside the lysosome increases the digestion of the particles, enhancing the release of ions that 
Nanostructure 
type
Surface 
coating
Nanostructure 
concentration
Average 
size
Cell line Cell viability Viability test References
Au NPs BSA – 20 nm HepG2 95% LDH assay [31]
Au NPs – 1 and 10 ppm 2–4, 
5–7 and 
20–40 nm 
diameter
J774 A1 
macrophages
Cell 
proliferation 
decreased to 
30–40% for all 
three sizes at 
10 ppm
Multisizer 
quantification
[40]
Au NRs PEG 0.5 mM 65 nm 
length 
and 
11 nm 
width
HeLa cells >90% MTT assay [45]
Ag NWs – 4 μg/cm2 100 nm 
diameter 
and 
28 μm 
length
THP-1 cells Significant 
decrease in cell 
proliferation 
and increase 
of membrane 
instability
Alamar Blue, 
LDH assay
[64]
SPIONs PEG 1 mg/mL for 
40–50 nm NPs, 
250 μg/mL for 
10–15 nm NPs
40–50 nm 
diameter, 
10–15 nm 
diameter
hTERT-BJ1 100% for 
40–50 nm 
NPs, 70% for 
10–15 nm NPs
MTT assay [75]
SPIONs – 100–250 μg/mL 47 nm BRL 3A rat 
liver cells
70% MTT, LDH 
assay
[53]
Fe NWs – 10,000 NWs 
per cell
10 μm 
length 
and 
50 nm 
diameter
HeLa cells No significant 
effect
MTT assay [98]
Ni NWs – 5 μg/mL 5.4 μm 
length 
and 
33 nm 
diameter
HCT 116 cells <80% MTT, LDH 
assay
[107]
Table 1. Summary of in vitro cytotoxicity studies with different kinds of nanoparticles (NPs) and nanowires (NWs), 
NWs with aspect ratio < 10 are often called nanorods (NR), SPION referred to superparamagnetic iron oxide NPs.
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affect the viability of the cells. However, the oxidation of Fe nanostructures did not decrease 
the cell viability.
Adding a coating to the nanostructure typically affected both the toxicity and the surface 
charge of the nanostructure, where cationic surfaces are more toxic than anionic. For instance, 
coating Au with TA coating led to the decrease of the cell viability to around 70%, whereas 
with a PEG coating, the viability was maintained above 90%.
The cytotoxicity of the nanomaterial depends also on the nanostructure’s shape. In this 
regard, several advantages have been reported for NWs over NPs. For instance, they enhance 
the drug-loading capacity, due to their large surface area. Moreover, magnetic NWs, due to 
their higher magnetization, can be better manipulated by the use of the magnetic field than 
NPs. An interesting observation from Figure 5 is that NWs/NRs are, on average, less cytotoxic 
than NPs. This was attributed to the increased interaction of the nanomaterial with the cells, 
due to the large surface area.
While all these studies contributed to obtain a better picture of the cytotoxicity of nanomateri-
als and the underlying mechanisms, it is a persisting issue that a consistent measurement and 
reporting system will be needed for future studies. This will not only enable performing more 
accurate comparisons of the toxicological characteristics of nanostructures but also to better 
evaluate the potential of using them for biomedical applications.
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